Pfizer Ltd. News and Updates

Keep track of all breaking news on Pfizer Ltd. from all sources in a single place.

01 Aug 2025

4993.00

-0.54%

Trump demands pharma companies slash US prices in blow to industry

Business Standard

In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower what they charge Medicaid for existing drugs

Pfizer Ltd. is trading above its 200 day SMA of 4894.5

Pfizer Ltd.

31 Jul 2025

4993.00

-0.54%

Trump Sets Sept 29 Deadline For J&J, Pfizer, Other Pharma Firms To Lower US Drug Prices

NDTV Profit

Donald Trump, in his letter to big pharma company CEOs, has demanded "most-favored-nation" pricing for Medicaid.

Pfizer Ltd. is trading below its 30 day SMA of 5390.4

Pfizer Ltd.

08 Jul 2025

4993.00

-0.54%

Dividend stocks: Pfizer, 6 others to go ex-date on July 9; do you own any?

Business Standard

Here is the complete list of stocks that will trade ex-dividend on July 9, following their announcements of dividend rewards for shareholders

Pfizer Ltd. is trading below its 30 day SMA of 5390.4

Pfizer Ltd.

31 May 2025

4993.00

-0.54%

Breast cancer: Pfizer-Arvinas drug beats AstraZeneca's in delaying disease's progression

Business Line

Trial finds Pfizer and Arvinas' experimental drug vepdegestrant increases survival without progression of breast cancer in patients with ESR1 mutations by five months

Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.

Pfizer Ltd.

23 May 2025

4993.00

-0.54%

FDA may change Covid-19 booster rules from 2025: What it means for you

Business Standard

The US Food and Drug Administration may limit Covid-19 boosters shots to high-risk groups from 2025; Pfizer reviewing proposal as agency seeks new trials, clearer risk labels for younger males

Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.

Pfizer Ltd.

20 May 2025

4993.00

-0.54%

Pfizer Q4 net profit jumps 85% to 331 crore; revenue rises 8.3%

Business Standard

Pfizer's Q4 profit surged to 331 crore, aided by a 172 crore gain from land sale; board declares 165 dividend per share, including special payouts for FY25

Pfizer Ltd. is trading below its 30 day SMA of 5390.4

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Business Standard | 20 May 2025

Pfizer Ltd.

12 May 2025

4993.00

-0.54%

Trump Vows US Drug Price Cuts Of Up To 80% In Pharma Industry Blow

NDTV Profit

Shares in US drugmakers dropped before the official open on trading in New York, with Eli Lilly & Co., Pfizer Inc., Bristol-Myers Squibb Co. and Merck & Co. Inc. all down.

Pfizer Ltd. is trading above its 200 day SMA of 4894.5

Pfizer Ltd.

29 Apr 2025

4993.00

-0.54%

Pfizer beats Q1 profit estimates on cost cut, strong sale of heart drug

Business Standard

It reported total revenue of $13.70 billion for the first quarter, compared with analysts' expectations of $13.91 billion, according to LSEG data

Pfizer Ltd. is trading below its 30 day SMA of 5390.4

Pfizer Ltd.

14 Apr 2025

4993.00

-0.54%

Pfizer ends development of promising obesity pill after safety concerns

Business Standard

According to the company's latest statement, one patient experienced a potential liver injury that may have been caused by the drug

Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.

Pfizer Ltd.

09 Apr 2025, 11:00PM

4993.00

-0.54%

Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump's US pharma tariff fears

livemint

US Markets Today: Pfizer, Amgen, and Johnson & Johnson were among other pharma stocks that dropped at the US market open on April 9 amid investor fears over Donald Trump's upcoming US pharma tariffs.

Pfizer Ltd. is trading below its 30 day SMA of 5390.4

Is Pfizer Ltd. worth buying?

207 Votes:

Buy 73.91%

Sell 14.98%

Hold 11.11%

34.91% Gain from 52W Low

Pfizer Ltd. News and Updates

Keep track of all breaking news on Pfizer Ltd. from all sources in a single place.